Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 273

1.

Multimodal analysis of the hippocampus in schizophrenia using proton magnetic resonance spectroscopy and functional magnetic resonance imaging.

Hutcheson NL, Reid MA, White DM, Kraguljac NV, Avsar KB, Bolding MS, Knowlton RC, den Hollander JA, Lahti AC.

Schizophr Res. 2012 Sep;140(1-3):136-42. doi: 10.1016/j.schres.2012.06.039. Epub 2012 Jul 23.

2.

Assessments of function and biochemistry of the anterior cingulate cortex in schizophrenia.

Reid MA, Stoeckel LE, White DM, Avsar KB, Bolding MS, Akella NS, Knowlton RC, den Hollander JA, Lahti AC.

Biol Psychiatry. 2010 Oct 1;68(7):625-33. doi: 10.1016/j.biopsych.2010.04.013. Epub 2010 Jun 8.

3.

Decoupling of N-acetyl-aspartate and glutamate within the dorsolateral prefrontal cortex in schizophrenia.

Coughlin JM, Tanaka T, Marsman A, Wang H, Bonekamp S, Kim PK, Higgs C, Varvaris M, Edden RA, Pomper M, Schretlen D, Barker PB, Sawa A.

Curr Mol Med. 2015;15(2):176-83.

4.

Regional decoupling of N-acetyl-aspartate and glutamate in schizophrenia.

Kraguljac NV, Reid MA, White DM, den Hollander J, Lahti AC.

Neuropsychopharmacology. 2012 Nov;37(12):2635-42. doi: 10.1038/npp.2012.126. Epub 2012 Jul 18.

5.

Increased hippocampal glutamate and volumetric deficits in unmedicated patients with schizophrenia.

Kraguljac NV, White DM, Reid MA, Lahti AC.

JAMA Psychiatry. 2013 Dec;70(12):1294-302. doi: 10.1001/jamapsychiatry.2013.2437.

PMID:
24108440
6.

Proton magnetic resonance spectroscopy of the substantia nigra in schizophrenia.

Reid MA, Kraguljac NV, Avsar KB, White DM, den Hollander JA, Lahti AC.

Schizophr Res. 2013 Jul;147(2-3):348-54. doi: 10.1016/j.schres.2013.04.036. Epub 2013 May 21.

7.

Brain metabolite alterations in young adults at familial high risk for schizophrenia using proton magnetic resonance spectroscopy.

Tandon N, Bolo NR, Sanghavi K, Mathew IT, Francis AN, Stanley JA, Keshavan MS.

Schizophr Res. 2013 Aug;148(1-3):59-66. doi: 10.1016/j.schres.2013.05.024. Epub 2013 Jun 20.

PMID:
23791389
8.

Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study.

Ohrmann P, Siegmund A, Suslow T, Pedersen A, Spitzberg K, Kersting A, Rothermundt M, Arolt V, Heindel W, Pfleiderer B.

J Psychiatr Res. 2007 Oct;41(8):625-34. Epub 2006 Sep 1.

PMID:
16949099
9.

Localized 1H-NMR spectroscopy in patients with fibromyalgia: a controlled study of changes in cerebral glutamate/glutamine, inositol, choline, and N-acetylaspartate.

Fayed N, Garcia-Campayo J, Magallón R, Andrés-Bergareche H, Luciano JV, Andres E, Beltrán J.

Arthritis Res Ther. 2010;12(4):R134. doi: 10.1186/ar3072. Epub 2010 Jul 7.

10.

Hippocampal-parietal dysconnectivity and glutamate abnormalities in unmedicated patients with schizophrenia.

Kraguljac NV, White DM, Hadley J, Reid MA, Lahti AC.

Hippocampus. 2014 Dec;24(12):1524-32. doi: 10.1002/hipo.22332. Epub 2014 Aug 1.

PMID:
25045047
11.

Metabolite changes and gender differences in schizophrenia using 3-Tesla proton magnetic resonance spectroscopy (1H-MRS).

Tayoshi S, Sumitani S, Taniguchi K, Shibuya-Tayoshi S, Numata S, Iga J, Nakataki M, Ueno S, Harada M, Ohmori T.

Schizophr Res. 2009 Mar;108(1-3):69-77. doi: 10.1016/j.schres.2008.11.014. Epub 2008 Dec 20.

PMID:
19097753
12.

A combined diffusion tensor imaging and magnetic resonance spectroscopy study of patients with schizophrenia.

Reid MA, White DM, Kraguljac NV, Lahti AC.

Schizophr Res. 2016 Feb;170(2-3):341-50. doi: 10.1016/j.schres.2015.12.003. Epub 2015 Dec 21.

PMID:
26718333
13.

Hippocampal pathology in schizophrenia: magnetic resonance imaging and spectroscopy studies.

Kegeles LS, Shungu DC, Anjilvel S, Chan S, Ellis SP, Xanthopoulos E, Malaspina D, Gorman JM, Mann JJ, Laruelle M, Kaufmann CA.

Psychiatry Res. 2000 May 15;98(3):163-75.

PMID:
10821999
14.

[Proton magnetic resonance spectroscopy and diffusion tensor imaging study of first-episode patients with positive symptoms of schizophrenia].

Jia YB, Wang Y, Ling XY, Zhong SM, Huang L.

Nan Fang Yi Ke Da Xue Xue Bao. 2012 Mar;32(3):374-8. Chinese.

15.

Analysis of brain metabolism by proton magnetic resonance spectroscopy (1H-MRS) in attention-deficit/hyperactivity disorder suggests a generalized differential ontogenic pattern from controls.

Arcos-Burgos M, Londoño AC, Pineda DA, Lopera F, Palacio JD, Arbelaez A, Acosta MT, Vélez JI, Castellanos FX, Muenke M.

Atten Defic Hyperact Disord. 2012 Dec;4(4):205-12. doi: 10.1007/s12402-012-0088-0. Epub 2012 Jul 20.

16.

Supplementation of antipsychotic treatment with sarcosine – GlyT1 inhibitor – causes changes of glutamatergic (1)NMR spectroscopy parameters in the left hippocampus in patients with stable schizophrenia.

Strzelecki D, Podgórski M, Kałużyńska O, Gawlik-Kotelnicka O, Stefańczyk L, Kotlicka-Antczak M, Gmitrowicz A, Grzelak P.

Neurosci Lett. 2015 Oct 8;606:7-12. doi: 10.1016/j.neulet.2015.08.039. Epub 2015 Aug 22.

PMID:
26306650
17.

Proton MR spectroscopy of the hippocampus at 3 T in patients with unipolar major depressive disorder: correlates and predictors of treatment response.

Block W, Träber F, von Widdern O, Metten M, Schild H, Maier W, Zobel A, Jessen F.

Int J Neuropsychopharmacol. 2009 Apr;12(3):415-22. doi: 10.1017/S1461145708009516. Epub 2008 Oct 10.

PMID:
18845018
18.

Proton magnetic resonance spectroscopy of the human brain in schizophrenia.

Deicken RF, Johnson C, Pegues M.

Rev Neurosci. 2000;11(2-3):147-58. Review.

PMID:
10718151
19.

Reduced frontal glutamate + glutamine and N-acetylaspartate levels in patients with chronic schizophrenia but not in those at clinical high risk for psychosis or with first-episode schizophrenia.

Natsubori T, Inoue H, Abe O, Takano Y, Iwashiro N, Aoki Y, Koike S, Yahata N, Katsura M, Gonoi W, Sasaki H, Takao H, Kasai K, Yamasue H.

Schizophr Bull. 2014 Sep;40(5):1128-39. doi: 10.1093/schbul/sbt124. Epub 2013 Sep 10.

20.

Mania, glutamate/glutamine and risperidone in pediatric bipolar disorder: a proton magnetic resonance spectroscopy study of the anterior cingulate cortex.

Moore CM, Biederman J, Wozniak J, Mick E, Aleardi M, Wardrop M, Dougherty M, Harpold T, Hammerness P, Randall E, Lyoo IK, Renshaw PF.

J Affect Disord. 2007 Apr;99(1-3):19-25. Epub 2006 Sep 26.

Supplemental Content

Support Center